Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma.
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma. Future Oncol. 2018 Feb; 14(5):417-430.
View in:
PubMed
subject areas
Adenocarcinoma
Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Clinical Trials as Topic
Esophageal Neoplasms
Esophagogastric Junction
Humans
Molecular Targeted Therapy
Neoplasm Metastasis
Neoplasm Staging
Programmed Cell Death 1 Receptor
Retreatment
Stomach Neoplasms
Treatment Outcome